Pharmacokinetics of Oral and Intravenous Oseltamivir Treatment of Severe Influenza B Virus Infection Requiring Organ Replacement Therapy
- 19 March 2016
- journal article
- case report
- Published by Springer Nature in European Journal of Drug Metabolism and Pharmacokinetics
- Vol. 42 (1) , 155-164
Abstract
Patients with severe influenza virus infection, multi-organ failure and organ replacement therapy may absorb and metabolize neuraminidase inhibitors differently. Systematic pharmacokinetic/pharmacodynamic clinical trials are currently lacking in this high-risk group. Inadequate dosing increases the risk of treatment failure and drug resistance, especially in severely ill patients with elevated virus loads. This study aims to explore the impact of organ replacement therapy on oseltamivir drug concentrations.Keywords
This publication has 49 references indexed in Scilit:
- Pharmacokinetics of Oseltamivir and Oseltamivir Carboxylate in Critically I ll Patients Receiving Continuous Venovenous Hemodialysis and/or Extracorporeal Membrane OxygenationPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2012
- Impact of Extracorporeal Membrane Oxygenation and Continuous Venovenous Hemodiafiltration on the Pharmacokinetics of Oseltamivir Carboxylate in Critically Ill Patients With Pandemic (H1N1) InfluenzaTherapeutic Drug Monitoring, 2012
- Viral shedding in children infected by pandemic A/H1N1/2009 influenza virusVirology Journal, 2011
- Intravenous Peramivir for Treatment of Influenza A and B Virus Infection in High-Risk PatientsAntimicrobial Agents and Chemotherapy, 2011
- Plasma Concentrations of Oseltamivir and Oseltamivir Carboxylate in Critically Ill Children on Extracorporeal Membrane Oxygenation SupportPLOS ONE, 2010
- Differentiation of Influenza B Virus Lineages Yamagata and Victoria by Real-Time PCRJournal of Clinical Microbiology, 2010
- Pharmacokinetics of oseltamivir: an oral antiviral for the treatment and prophylaxis of influenza in diverse populationsJournal of Antimicrobial Chemotherapy, 2010
- Intensive care adult patients with severe respiratory failure caused by Influenza A (H1N1)v in SpainCritical Care, 2009
- Pharmacokinetics of High-Dose Oseltamivir in Healthy VolunteersAntimicrobial Agents and Chemotherapy, 2009
- Influenza-Associated Hospitalizations in the United StatesJAMA, 2004